Search

everythinglearnresearchcommunity

for

Search:↓

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Five FDA-approved drugs may help block COVID-19 virus entry.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

Ritlecitinib works well and is safe for treating alopecia areata.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Tocilizumab might be an effective treatment for COVID-19.

A 12-year-old boy had severe shingles and skin damage after a stem-cell transplant.

Some gonadal hormone drugs can block filovirus entry into cells.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

A 13-year-old girl with various symptoms was successfully treated for autoimmune disease using the antibiotic co-trimoxazole.

Acyclovir can prevent rejection of skin grafts in herpes-related lip leucoderma.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.